Art

J-GLOBAL ID：202002250235163338   Reference number：20A0029124

Tertiary lymphoid organs in the inflammatory myopathy associated with PD-1 inhibitors

PD-1阻害剤に関連する炎症性ミオパチーにおける三次リンパ器官【JST・京大機械翻訳】

Author (5)： Matsubara Shiro (Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan) ,  Seki Morinobu (Department of Neurology, Keio University School of Medicine, Tokyo, Japan) ,  Suzuki Shigeaki (Department of Neurology, Keio University School of Medicine, Tokyo, Japan) ,  Komori Takashi (Department of Neuropathology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan) ,  Takamori Mikio (Respiratory / Medical Oncology Department, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan)
Material： Journal for ImmunoTherapy of Cancer (Web)
Volume： 7  Issue： 1  Page： 1-7  Publication year： 2019 
JST Material Number： U7507A  ISSN： 2051-1426  Document type： Article
Article type： 短報  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Programmed cell death 1 inhibi...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0029124&from=J-GLOBAL&jstjournalNo=U7507A") }}

Thesaurus term： cytotoxic T cell ,  Polymyositis ,  immunohistochemistry ,  macrophage ,  *Lymph ,  *Inflammation ,  ovarian follicle ,  endothelial cell ,  *muscular disease ,  blood vessel ,  muscle fiber ,  effectiveness ,  lymphocyte ,  Necrosis ,  *organ ,  *body fluid

JST classification (3)： Immunological reaction in general  (ED03010T) ,  Immunotherapy for tumors  (GE03035B) ,  Chemistry,biochemistry and pathology of tumors(=neoplasms)  (GE02030N)

Reference (24)：

• Immunotherapy.; Immune checkpoint blockade in human cancer therapy: lung cancer and hematologic malignancies; M Janakiram, V Pareek, VH Cheng, DM Narasimhulu, X Zang; 8; 2016; 809-819; 10.2217/imt-2016-0001; citation_id=CR1
• Neurology; Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer; M Touat, T Maisonobe, S Knauss, H Ben, O Salem, BB Hervier; 91; 2018; e985-e994; 10.1212/WNL.0000000000006124; citation_id=CR2
• Seki M, Uruha A, Ohnuki Y, Kamada S, Noda T, Onda A, et al. Inflammatory myopathy associated with PD-1 inhibitor. J Autoimmunity. 2019.https://doi.org/10.1016/j.aut.2019.03.005.
• Immunol Lett; Plasticity and heterogeneity of lymphoid organs. What are the criteria to call a lymphoid organ primary, secondary or tertiary?; R Pabst; 112; 2007; 1-8; 10.1016/j.imlet.2007.06.009; citation_id=CR4
• Nat Commun; Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity; JD Peske, ED Thompson, L Gemta, RA Baylis, YX Fu, VH Engelhard; 6; 2015; 7114; 10.1038/ncomms8114; citation_id=CR5

Terms in the title (3)： PD-1阻害剤 ,  炎症 ,  ミオパチー